Aadi Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Net Income	-68.83	-65.77	-60.51	-110.74	-4.47	-23.27	Upgrade
Depreciation & Amortization	0.64	0.63	0.54	0.28	0.18	0.08	Upgrade
Share-Based Compensation	12.8	11.95	9.64	2.11	0.14	1.09	Upgrade
Other Operating Activities	-2.62	-6.48	0.69	85.29	-9.54	-1.74	Upgrade
Operating Cash Flow	-58.01	-59.66	-49.64	-22.42	-12.7	-23.85	Upgrade
Capital Expenditures	-3.34	-3.97	-0.44	-0.05	0	-0.24	Upgrade
Acquisitions	0	0	0	25.2	0	0	Upgrade
Change in Investments	80.77	87.18	-132.44	0	0	0	Upgrade
Investing Cash Flow	77.43	83.21	-132.89	25.15	0	-0.24	Upgrade
Dividends Paid	0	0	0	-4.41	0	0	Upgrade
Share Issuance / Repurchase	0.48	0.49	73.28	155.83	0	0	Upgrade
Debt Issued / Paid	0	0	0	0	1.19	0	Upgrade
Other Financing Activities	-0.17	-0.16	-0.66	-9.62	-	-	Upgrade
Financing Cash Flow	0.31	0.33	72.62	141.8	1.19	0	Upgrade
Net Cash Flow	19.73	23.87	-109.91	144.53	-11.51	-24.09	Upgrade
Free Cash Flow	-61.35	-63.64	-50.08	-22.47	-12.7	-24.09	Upgrade
Free Cash Flow Margin	-257.33%	-261.29%	-329.15%	-2006.16%	-87.11%	-	Upgrade
Free Cash Flow Per Share	-2.27	-2.36	-2.23	-2.52	-5.00	-8.90	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).